Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
192 hedge funds and large institutions have $3.24B invested in Inari Medical, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 74 increasing their positions, 63 reducing their positions, and 21 closing their positions.
125% more call options, than puts
Call options by funds: $17.8M | Put options by funds: $7.92M
52% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 21
21% more capital invested
Capital invested by funds: $2.67B → $3.24B (+$572M)
17% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 63
5% more funds holding
Funds holding: 182 → 192 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$95.3M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$51.7M |
| 3 |
Jennison Associates
New York
|
+$41.1M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$34.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$132M |
| 2 |
DCP
Darsana Capital Partners
New York
|
-$116M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
-$22M |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$13.6M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$13.4M |
NARI Hedge Fund Activity: Q4 2021 in Review
192 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q4 2021, worth a combined $3.24B — up 21% from $2.67B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new NARI positions and 21 closed out — a net gain of 11 holders — while 74 added to existing stakes and 63 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $95.3M. The largest seller was Wells Fargo, cutting an estimated $132M.
- 192 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q4 2021, up from 182 in Q3 2021.
- Funds reported $3.24B of Inari Medical, Inc. Common Stock stock for Q4 2021, up 21% quarter-over-quarter.
- 32 funds opened new Inari Medical, Inc. Common Stock positions in Q4 2021 and 21 closed out, a net change of +11 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q4 2021 was Wellington Management Group, an estimated $95.3M added.
- The largest Inari Medical, Inc. Common Stock seller in Q4 2021 was Wells Fargo, an estimated $132M sold.
Based on aggregated 13F filings for Q4 2021.